BIG PHARMA POLITICS: Consumers pressure politicians to do something about rising drug prices. Read More
Tracking the mergers, acquisitions and business moves within the U.S. pharmaceutical industry can be a good way to predict how consumers will be ultimately affected.
Bob Herman, a reporter at Axios, recently posted a story that looks at how and why companies are expanding their reach into the manufacturing and marketing of anticancer medications.
This year alone, Herman counts four instances of industry titans spending billions to acquire smaller companies in the cancer treatment business.
There’s no better way, Herman concludes, to secure the patents and the ability to control future price increases. What’s more, he writes, these anticancer drugs demand huge prices that health insurers and consumers usually pay without question.
What about you? Have you or a loved one felt you had little choice but to pay thousands for a cancer medication? Share your experience with Voices for Affordable Health.